API
< Back to situations

[PERSON]

Ozempic

Featured in 8 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [BR] [ES] [IN]

Semaglutide market developments in Brazil and Spain

2 clusters · 2 sources · last updated

Latest: Novo Nordisk launches 2 mg Ozempic dose in Spain

Developments regarding semaglutide treatments have emerged in Brazil and Spain. In Brazil, Dr Reddy’s Laboratories secured marketing authorization from the National Health Surveillance Agency (ANVISA) to sell a generic v

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

343 clusters · 1318 sources · last updated

Latest: FDA issues warning for GLP-1 drugs over vision loss risks

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt

[QUIET] [HEALTH] [US] [AR] [CA]

Eli Lilly EloraTZP and retatrutide obesity drug clinicals

4 clusters · 38 sources · last updated

Latest: Eli Lilly's retatrutide outperforms Ozempic in weight loss trial

Eli Lilly has reported results from Phase 2b clinical trials for EloraTZP, a combination therapy involving eloralinantide and tirzepatide designed to treat obesity and type 2 diabetes. Data indicates the combination tar

Also covered in